STAT News

OCTOBER 20, 2022

Amid a push to widen access to medicines to poor countries, Novartis has reached an agreement to license one of its best-selling cancer treatments so that generic manufacturers can produce copies for distribution to 44 low- and middle-income nations. Continue to STAT+ to read the full story…

Licensing 98

Licensing Licensing Medicine Manufacturing 98

STAT News

JULY 28, 2022

In a much ballyhooed move, ViiV Healthcare finalized a deal to license its long-acting injectable HIV prevention shot to the Medicines Patent Pool so that generic companies can make and distribute lower-cost versions to low- and middle-income countries.

Licensing 98

Licensing Licensing Medicine Manufacturing 98

Pharmaceutical Technology

MARCH 31, 2023

On March 30, ViiV Healthcare and Medicines Patent Pool (MPP), announced sublicensing agreements with the pharma manufacturers Aurobindo , Cipla and Viatris to produce generic forms of the long-acting cabotegravir used as pre-exposure prophylaxis (PrEP) for HIV.

Medicine 130

Medicine Manufacturing Pharma Companies Licensing 130

Pharmaceutical Technology

DECEMBER 27, 2022

Indian pharmaceutical company Hetero has received the World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its Nirmacom (nirmatrelvir). It intends to manufacture the drug at its facility in India.

Licensing 195

Licensing Licensing Containment Medicine 195

Pharmaceutical Technology

MARCH 2, 2023

Additionally, due to the acquisition of Exelead, a biopharmaceutical contract development and manufacturing company, sales increased by 0.4%. The increase in sales was due to new medicines. Favourable foreign exchange effects of 6.1% resulted primarily from the development of the US dollar and the Chinese renminbi. in organic sales.

Sales 245

Sales Life Science Licensing Licensing 245

Pharmaceutical Technology

AUGUST 12, 2022

Each month, an estimated 37 million packs of medicines are shipped between the EU and the UK, with 45 million traded in the opposite direction. Following the introduction of customs controls in January 2021, medicine imports from the EU fell to their lowest levels in years. Industry figures have spoken out against this prospect.

Medicine 290

Medicine Production Generic Drugs Regulation 290

pharmaphorum

OCTOBER 27, 2021

Merck & Co has signed a licensing deal with the UN-backed Medicines Patent Pool (MPP) that could pave the way for generic companies to manufacture its much-anticipated oral antiviral for COVID-19. ” Under the agreement, MPP will sublicense manufacturing rights to other drugmakers.

Licensing 143

Licensing Licensing Manufacturing Clinical Trials 143

FDA Law Blog

DECEMBER 3, 2023

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). CMS will send the final manufacturer invoice for discount liabilities accrued by then on April 30, 2028.

Manufacturing 105

Manufacturing Drugs Compliance Pharmacy 105

BioPharma Reporter

DECEMBER 7, 2023

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a Â1 million investment.

Licensing 96

Licensing Licensing Medicine Production 96

Fossil Remedies

OCTOBER 16, 2022

The next important consideration is a proper distribution channel from the manufacturer to end customers. In a pharma business, you have a distribution network like a pharma manufacturing company, pharma marketing company, C&F agents, wholesalers/distributors/stockiest, retailers, and pharmacies. Wholesale Drug License.

Licensing 52

Licensing Licensing Pharma Companies Manufacturing 52

pharmaphorum

OCTOBER 21, 2022

The Medicines Patent Pool (MPP) and Novartis have unveiled a new voluntary licensing agreement to allow generic drugmakers in seven middle income nations to develop, manufacture, and supply generic versions of the leukaemia treatment nilotinib. Patents on the product are pending or in force in these seven chosen nations.

Medicine 59

Medicine Licensing Licensing Drugs 59

STAT News

MARCH 22, 2023

National Institutes of Health rejected a petition urging the agency to use a controversial provision of federal law to widen access to a cancer drug by forcing the manufacturers to license their patents. The medicine was developed at the University of California, Los Angeles, with help from U.S.

Licensing 98

Licensing Licensing Manufacturing Drugs 98

Pharmaceutical Technology

OCTOBER 14, 2022

The two companies will aim to improve the manufacturing and analytic procedures used to develop personalised cell and gene therapies to treat cancer patients. The two companies will aim to improve the manufacturing and analytic procedures used to develop personalised cell and gene therapies to treat cancer patients.

Gene Therapy 130

Gene Therapy Gene Development Manufacturing 130

STAT News

JANUARY 11, 2023

… Merck plans to take legal action against several pharmaceutical companies in China after noticing that some manufacturers were supplying Covid-19 drugs to some provinces and cities saying the medicines were authorized by Merck , Reuters reports. Have a wonderful day, and please do stay in touch.

Gene Therapy 98

Gene Therapy Licensing Licensing Gene 98

Fierce Pharma

SEPTEMBER 14, 2023

Astellas will build its third Irish manufacturing facility. Astellas will build its third Irish manufacturing facility for $354 million. Insilico Medicine out-licensed an AI-discovered cancer drug candidate to Exelixis. Otsuka teamed up with Shape Therapeutics in an eye disease gene therapy deal potentially worth $1.5

Gene Therapy 79

Gene Therapy Gene Licensing Licensing 79

pharmaphorum

OCTOBER 12, 2022

By remaining compliant, medicines are manufactured in line with their pre-defined and approved specifications, in order to ensure the delivery of safe and effective products to consumers. So, with mandates in place, how do manufacturing facilities meet these compliance goals? The dominion of data. About the author.

Compliance 105

Compliance Manufacturing Life Science Production 105

Pharmaceutical Technology

FEBRUARY 3, 2023

Under the deal, Karuna will have an exclusive worldwide licence for the development, manufacturing, and commercialisation of multiple Goldfinch Bio’s TRPC4/5 candidates, including GFB-887, the lead clinical-stage candidate. Additionally, the company will receive a royalty on net sales of each licensed product.

Licensing 130

Licensing Licensing Sales Development 130

pharmaphorum

MARCH 16, 2021

Indiana-based radiopharmaceutical Contract Development and Manufacturing Organization expands nuclear pharmacy capabilities with second location . SpectronRx , a leading radiopharmaceutical contract development and manufacturing organization (CDMO), announced today that the U.S. To learn more, visit SpectronRx.com.

Licensing 52

Licensing Licensing Manufacturing Pharmacy 52

pharmaphorum

MAY 20, 2022

Several of the top pharmaceutical companies have joined a new coalition that aims to improve access to cancer medicines in low- and lower-middle-income countries (LLMICs). It is taking a broader approach, making sure patients living with cancer “receive the medicines they need at the right time,” he said.

Drugs 111

Drugs Medicine Licensing Licensing 111

Pfizer

JULY 19, 2022

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.1 is immunocompromised or are on a medicine that affects the immune system. 1 Adapted Bivalent Vaccine Candidate. Tue, 07/19/2022 - 11:22. has a fever.

Vaccine 100

Vaccine Vaccination Medicine Clinical Trials 100

Pharmaceutical Technology

MAY 25, 2023

Adalvo has entered a strategic licensing agreement with Swiss pharmaceutical company EQL Pharma for Mellozzan (melatonin) outside Europe and the US. With a network of more than 134 local pharmaceutical companies, Adalvo supplies more than 110 different medicines in over 100 countries across the world.

Hormones 130

Hormones Engineer Containment Licensing 130

Scienmag

AUGUST 20, 2020

VA seeking companies to license, manufacture Credit: Dr. Scott Fuller/VA SACRAMENTO, Calif. – An ear, nose, and throat doctor has invented a simple mask design that significantly improves safety during aerosol-generating procedures of the head and neck.

Doctor 95

Doctor Doctors Licensing Licensing 95

Pharmaceutical Technology

NOVEMBER 9, 2022

CSL Behring has a commercialisation and license agreement to develop EtranaDez. On November 7, the company announced that the FDA has scheduled a pre-licensure inspection of BioMarin’s manufacturing facility, and required the company to submit three-year Phase III Roctavian data in the approval application.

Gene Therapy 278

Gene Therapy Gene FDA Approval Medicine 278

Pharmaceutical Technology

MAY 30, 2023

The European Medicines Agency has also approved Efmody for the treatment of congenital adrenal hyperplasia medicine in patients ages 12 years and above in the European Union. Separate from drug development, the Italian company also offers contract manufacturing and clinical supply services.

Contract Manufacturing 130

Contract Manufacturing Clinical Supply Drugs Licensing 130

Pfizer

SEPTEMBER 28, 2022

Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5-Adapted 1-adapted bivalent vaccine, non clinical and manufacturing data from the companies’ 10-µg Omicron BA.4/BA.5-adapted

Vaccine 101

Vaccine Vaccination Medicine Clinical Trials 101

BioPharma Reporter

APRIL 20, 2023

CDMO Sterling Pharma Solutions has been granted a Manufacturerâs Authorisation for Investigational Medicinal Products from the UKâs Medicines and Healthcare products Regulatory Agency (MHRA).

Licensing 52

Licensing Licensing Antibody Manufacturing 52

pharmaphorum

NOVEMBER 29, 2021

The UK’s Vaccines Manufacturing and Innovation Centre (VMIC) – unveiled with fanfare by the government in 2018 – is rumoured to be up for sale. It was billed at the time as a key tool to accelerate the development of new and innovative vaccines to combat some of the world’s most prevalent diseases, from discovery to licensed product.

Vaccine 105

Vaccine Vaccination Manufacturing Pharma Companies 105

The Pharma Data

NOVEMBER 17, 2021

The agreement will enable MPP to grease fresh product and distribution of the investigational antiviral, pending nonsupervisory authorization or blessing, by grantingsub-licenses to good general drug manufacturers, with the thing of easing lesser access to the global population. This press release features multimedia.

Licensing 52

Licensing Licensing Medicine Manufacturing 52

Pharmaceutical Technology

AUGUST 23, 2022

The FDA also sought the vaccine’s pre-clinical and manufacturing data for addressing the SARS-CoV-2 virus’ evolution. The companies have also commenced rolling submission for conditional marketing authorization from the European Medicines Agency (EMA) for this Omicron BA.4/BA.5-adapted 1-adapted vaccine. 5-adapted bivalent vaccine.

Vaccine 130

Vaccine Vaccination Gene Therapy Protein 130

Pharmaceutical Technology

SEPTEMBER 28, 2022

Seagen and Lava Therapeutics have entered an exclusive licence agreement for the development, manufacturing and commercialisation of the latter’s LAVA-1223 for solid tumours. An advanced preclinical asset, LAVA-1223 is a bispecific T cell engager. It can act on and activate V?9V?2

Development 130

Development Licensing Licensing Production 130

pharmaphorum

JANUARY 20, 2022

Twenty-seven drug makers have signed onto a deal to manufacture a generic version of molnupiravir , Merck’s oral antiviral for the treatment of COVID-19. We are pleased to see this vision come to life, with strong geographic diversity in MPP’s selected generic manufacturing sublicensees.”.

Drugs 75

Drugs Licensing Licensing Manufacturing 75

pharmaphorum

OCTOBER 7, 2021

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. “We expect to manufacture our COVID-19 vaccine as well as additional products within our mRNA vaccine portfolio at this facility.”

Vaccine 98

Vaccine Vaccination Manufacturing Packaging 98

The Pharma Data

SEPTEMBER 6, 2021

Takeda today announced that the Government of Japan’s Ministry of Health, Labour and Welfare (MHLW) will purchase 150 million doses of Novavax’ vaccine candidate (TAK-019 in Japan) manufactured in Japan by Takeda subject to licensing and approval. The details of the terms and conditions of the agreement are confidential.

Manufacturing 52

Manufacturing Vaccine Vaccination Clinical Trials 52

Pharmacy Checkers

DECEMBER 5, 2019

A new Chinese law (in effect as of December 1, 2019) makes third-party online platform medicine sales legal, appropriately ends a draconian definition of counterfeit drugs, and effectively decriminalizes personal drug importation, but with a lot of gray! that online retail giants Alibaba and JD were selling medicines in a gray area of law.

Sales 64

Sales Medicine Pharmacy Drugs 64

The Pharma Data

MAY 27, 2022

ViiV Healthcare and MPP are actively negotiating voluntary licensing terms to help widen access to innovative HIV prevention measure . Widening access for an injectable such as this is complex and will take all stakeholders playing their part. Shionogi B.V. joined in October 2012. Source link: www.viivhealthcare.com. .

Medicine 52

Medicine Licensing Licensing Manufacturing 52

pharmaphorum

NOVEMBER 24, 2020

The combined company will cover a broad swathe of the digital health landscape, bringing together population health software, telehealth services, digital pharmacy delivering compounded and manufactured medicines, and tech enabled behavioural health services for people with mental health and substance abuse issues.

Behavioural Health 138

Behavioural Health Pharmacy Packaging Packaging 138

Pharmaceutical Technology

FEBRUARY 15, 2023

RNA has the potential to underpin breakthrough treatments for a wide variety of diseases, including many cancers, and transform medicine as we know it. But the mRNA technology is not yet mature and there are no standardised manufacturing protocols yet. Polydispersity is the range of particle sizes produced during manufacturing.

Bioassay 130

Bioassay RNA Development Drugs 130